O cotidiano, o lúdico e as redes relacionais: a artesania do cuidar em terapia ocupacional no hospital

O objetivo deste trabalho é refletir sobre os modos de fazer, sentir e conduzir as ações de contar histórias em uma enfermaria pediátrica. Essas ações decorrem de atividades de extensão universitária, no âmbito da terapia ocupacional. A reflexão, realizada a partir da revisão de literatura e discussão sobre anotações de campo do projeto, pauta-se por norteadores teóricos baseados nas tecnologias do cuidado e no brincar dentro do contexto das intervenções no hospital, sob a perspectiva da integralidade e da humanização do cuidado. A contação de histórias é apresentada enquanto forma de promover escuta, acolhimento, afetações diversas e processos vinculares, possibilitando a constituição de uma rede de sustentabilidade relacional, envolvendo os atores que circulam na enfermaria. Reafirma, assim, as práticas profissionais em saúde no hospital a partir de uma construção permanente junto ao sujeito por meio de ferramentas tecnológicas singularizadoras que promovam encontros-acontecimentos.

Ocupação, bem-estar e satisfação de vida: a experiência de um modelo alternativo de estágio em terapia ocupacional na Austrália

Apresenta-se um modelo alternativo de estágio em terapia ocupacional desenvolvido na Deakin University - Austrália, denominado Ocupação, bem-estar e satisfação de vida - Occupation, wellness and life-satisfaction (OWLS). O OWLS oferece, aos estudantes, a oportunidade de atuação em contextos não tradicionais, permitindo um aprendizado estratégico em ambientes não clínicos, incluindo o trabalho com outros profissionais não-terapeutas ocupacionais e com diferentes culturas de trabalho e práticas, em resposta a lacunas identificadas na comunidade. Favorece oportunidades para desenvolver habilidades, tais como: a promoção da saúde, avaliação e educação em saúde e intervenção em escolas, melhorando, assim, a saúde e o bem-estar da comunidade. O programa tem contribuído para o desenvolvimento de novos projetos, com resultados positivos alcançados pelos estudantes, representando uma importante estratégia de ensino para capacitação do profissional de terapia ocupacional, ampliando, assim, a área de atuação.

Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection

Background  Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), infective dermatitis associated with HTLV-1 (IDH), and various other clinical conditions. Several of these diseases can occur in association. Objective  Report an association of diseases related to HTLV-1 infection, occurring in an unusual age group. Methods  Dermatological and laboratory exams were consecutively performed in HTLV-1-infected individuals from January 2008 to July 2010 in the HTLV Outpatient Clinic at the Institute of Infectious Diseases “Emilio Ribas” in São Paulo, Brazil. Results  A total of 193 individuals (73 HAM/TSP and 120 asymptomatic carriers) were evaluated, three of which were associated with adult-onset IDH and HAM/TSP. In all three cases, the patients were affected by IDH after the development and progression of HAM/TSP-associated symptoms. Limitations  Small number of cases because of the rarity of these diseases. Conclusion  We draw attention to the possibility of co-presentation of adult-onset IDH in patients with a previous diagnosis of HAM/TSP, although IDH is a disease classically described in children. Thus, dermatologists should be aware of these diagnoses in areas endemic for HTLV-1 infection.

Position paper on diagnosis and treatment of atopic dermatitis

The diagnosis of atopic dermatitis (AD) is made using evaluated clinical criteria. Management of AD must consider the symptomatic variability of the disease.

Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy

Recent published work on atopic dermatitis focusing on the pathogenesis and epidemiology, which have a direct effect on treatment, is presented.

Systemic therapy of atopic dermatitis in children and adults

Systemic therapy is required in patients with severe atopic dermatitis (AD) refractory to adequate topical therapy. The aim of a systemic therapy is the rapid and efficient improvement of skin symptoms and pruritus in acute exacerbation and/or the long-term control of severe chronic disease. A number of immunosuppressive and immunomodulating substances are available that may efficiently reduce skin inflammation and thus lead to a relief of symptoms including pruritus. The excellent effects of cyclosporine as short-term as well as maintenance therapy have been documented in several studies in children and adults. Furthermore, other immunosuppressive substances such as azathioprine, mycophenolate mofetil and methotrexate are effective in patients with moderate to severe AD. Intravenous immunoglobulins and γ-interferon exert immunomodulatory effects and thus may improve severe AD. Biological agents are a new approach in AD therapy since they may specifically target cells, cytokines or mediators involved in the pathogenesis of AD.

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

BACKGROund: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool.

Atopic dermatitis - from new pathophysiologic insights to individualized therapy

Recently, important novel insights into the complex pathophysiology of atopic dermatitis (AD) have been gained. However, in most cases the therapy of AD is limited to base line therapy with emollients combined with symptomatic, rather general immunosuppressive treatment approaches of the flare-ups. Latest research findings together with experiences from daily clinical practice, which support the concept that a combination of general disease features together with specific trigger factors in the individual patients drive the disease, might be helpful for a subclassification of patients with AD based on the most relevant pathophysiologic modifications. Subclassification of patients with AD seems indispensable to introduce rationale-based, individualized treatment approaches of AD, which target specific modified pathways. In this review, we provide an overview about a selection of pathophysiologic pathways, which hold promise to represent targets of such therapeutic approaches in the near future.